Squarepoint Ops LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 47 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 2.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2019$122,000
+221.1%
53,618
+20.3%
0.00%
Q3 2019$38,000
+40.7%
44,569
+62.4%
0.00%
Q2 2019$27,000
-75.2%
27,449
-68.3%
0.00%
-100.0%
Q1 2019$109,000
+87.9%
86,723
+313.7%
0.00%0.0%
Q2 2018$58,000
-78.7%
20,962
-55.1%
0.00%
-80.0%
Q4 2017$272,000
+174.7%
46,718
-0.7%
0.01%
+150.0%
Q3 2017$99,000
+94.1%
47,034
+331.9%
0.00%
+100.0%
Q2 2017$51,000
-61.1%
10,891
-34.9%
0.00%
-75.0%
Q1 2017$131,000
-72.8%
16,723
-57.4%
0.00%
-80.0%
Q4 2016$482,00039,2990.02%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q1 2020
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders